News PRESS RELEASES Featured Jan 9, 2026 Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases Jan 9, 2026 Read More → Jan 9, 2026 IN THE NEWS Featured Mar 1, 2026 Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye Mar 1, 2026 Cell & Gene Mar 1, 2026 Feb 17, 2026 Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That. Feb 17, 2026 Forbes Feb 17, 2026 Feb 12, 2026 Biotech CEOs discuss the state of the industry, what is needed to compete globally, the importance of having a patient-centric approach, and more Feb 12, 2026 Biotech TV Feb 12, 2026 Jan 21, 2026 JPM 2026: Aurora Therapeutics’ Edward Kaye on Scalable Personalized Gene Editing Jan 21, 2026 Inside Precision Medicine Jan 21, 2026 Jan 9, 2026 Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies Jan 9, 2026 BioPharma Dive Jan 9, 2026 Jan 9, 2026 Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines Jan 9, 2026 STAT Jan 9, 2026 Jan 9, 2026 Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments Jan 9, 2026 Wired Jan 9, 2026 Jan 9, 2026 Gene editing pioneers launch first startup focused on custom CRISPR therapies Jan 9, 2026 Endpoints News Jan 9, 2026
